Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations

1. World Health Organization 2008 Scaling up care for mental, neurological, and substance use disorders. Available: http://www.who.int/mental_health/mhgap_final_english.pdf. Accessed 10 October 2011

2. PrinceMPatelVSaxenaSMajMMaselkoJ 2007 No health without mental health. Lancet 370 859 877

3. SaxenaSThornicroftGKnappMWhitefordH 2007 Resources for mental health: scarcity, inequity and inefficiency. Lancet 370 878 889

4. PatelVArayaRChatterjeeSChisholmDCohenA 2007 Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet 370 991 1005

5. JacobKSSharanPMirzaIGarrido-CumbreraMSeedatS 2007 Mental health systems in countries: where are we now? Lancet 370 1061 1077

6. SaracenoBvan OmmerenMBatnijiRCohenAGurejeO 2007 Barriers to improvement of mental health services in low-income and middle-income countries. Lancet 370 1164 1174

7. ChisholmDFlisherAJLundCPatelVSaxenaS 2007 Scale up services for mental disorders: a call for action. Lancet 370 1241 1252

8. World Health Organization 2008 The global burden of disease: 2004 update. Available: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf. Accessed 10 October 2011

9. World Health Organization 2010 Packages of interventions for family planning, safe abortion care, maternal, newborn and child health. Available: http://whqlibdoc.who.int/hq/2010/WHO_FCH_10.06_eng.pdf. Accessed 10 October 2011

10. CollinsPYPatelVJoestlSSMarchDInselTR 2011 Grand challenges in global mental health. Nature 475 27 30

11. PatelVThornicroftG 2009 Packages of care for mental, neurological, and substance use disorders in low- and middle-income countries. PLoS Med 6 e1000160 doi:10.1371/journal.pmed.1000160

12. BarbuiCDuaTvan OmmerenMYasamyMTFleischmannA 2010 Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders. PLoS Med 7 e1000322 doi:10.1371/journal.pmed.1000322

13. BloomrosenMDetmerDE 2010 Informatics, evidence-based care, and research; implications for national policy: a report of an American Medical Informatics Association health policy conference. J Am Med Inform Assoc 17 115 123

14. WeinmannSKoestersMBeckerT 2007 Effects of implementation of psychiatric guidelines on provider performance and patient outcome: systematic review. Acta Psychiatr Scand 115 420 433

15. KnaupCKoestersMSchoeferDBeckerTPuschnerB 2009 Effect of feedback of treatment outcome in specialist mental healthcare: meta-analysis. Br J Psychiatry 195 15 22

16. GrimshawJMThomasREMacLennanGFraserCRamsayCR 2004 Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8 iii iv, 1–72

17. TansellaMThornicroftG 2009 Implementation science: understanding the translation of evidence into practice. Br J Psychiatry 195 283 285

18. World Health Organization 2010 mhGAP intervention guide for for mental, neurological, and substance use disorders in non-specialized settings. Available: http://www.who.int/mental_health/evidence/mhGAP_intervention_guide/en/index.html. Accessed 10 October 2011

19. ChisholmDSandersonKAyuso-MateosJLSaxenaS 2004 Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry 184 393 403

20. ChisholmD WHO-CHOICE 2005 Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis. Epilepsia 46 751 759

21. WHO 2011 mhGAP newsletter. June 2011. Available: http://www.who.int/mental_health/mhGAP_nl__jun2011_en.pdf. Accessed 15 October 2011

22. University of Cape Town 11 February 2011 New project to PRIME mental health services. Available: http://www.uct.ac.za/print/dailynews/?id=7691. Accessed 10 October 2011

23. BarbuiCCiprianiAPatelVAyuso-MateosJLvan OmmerenM 2011 Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry 198 11 16, sup 1

24. KirschIDeaconBJHuedo-MedinaTBScoboriaAMooreTJ 2008 Initial severity and antidepressant benefits: a metaanalysis of data submitted to the Food and Drug Administration. PLoS Med 5 e45 doi:10.1371/journal.pmed.0050045

25. RathboneJSoares-WeiserK 2006 Anticholinergics for neuroleptic-induced acute akathisia. Cochrane Database Syst Rev 4 CD003727

26. FowleAJBinnieCD 2000 Uses and abuses of the EEG in epilepsy. Epilepsia 41 Suppl 3 S10 S18

27. EngelJJr 1984 A practical guide for routine EEG studies in epilepsy. J Clin Neurophysiol 1 109 142

28. BenbadisSRTatumWO 2003 Overintepretation of EEGs and misdiagnosis of epilepsy. J Clin Neurophysiol 20 42 44

29. RosnerSLeuchtSLehertPSoykaetM 2008 Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. Psychopharmacology 22 11 23

30. GhumanJKArnoldLEAnthonyBJ 2008 Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice. J Child Adolesc Psychopharmacol 18 413 447

31. NICE 2009 Attention deficit hyperactivity disorder. The NICE guideline on diagnosis and management of ADHD in children, young people and adults. Section 7.2.14. From evidence to recommendations: psychological interventions for children and young people with ADHD. NICE technology appraisal 72 London National Institute for Health and Clinical Excellence

32. KingSGriffinSHodgesZWeatherlyHAsseburgC 2006 A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technol Assess 10 1 162

33. BanerjeeS 2009 The use of antipsychotic medication for people with dementia: time for action. A report for the Minister of State for Care Services. London: Department of Health. Available: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_108302.pdf. Accessed 10 October 2011

34. BeautraisALJoycePRMulderRTFergussonDMDeavollBJ 1996 Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. Am J Psychiatry 153 1009 1014

35. LejoyeuxMHuetFClaudonMFichelleACasalinoE 2008 Characteristics of suicide attempts preceded by alcohol consumption. Arch Suicide Res 12 30 38

36. DenisCLavieEFatseasMAuriacombeM 2006 Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database of Systematic Reviews 3 CD005336